from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1816/-

LFCtreatmentdescriptionclass of inhibitor

0.156

Amikacinug/mL Amikacintranslation

1.474

Cap5-10ug/mL Capreomycintranslation

3.963

Rox10-50 ug/mL Roxithromycintranslation

-0.351

SM2-5 ug/mL Streptomycintranslation

1.141

Tet5-10 ug/mL Tetracyclinetranslation

-0.907

Rif0.2-5ug/mL Rifampicintranscription

0.993

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.072

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.181

CPZ10-50 ug/mL Chlorpromazinerespiration

0.482

Clofazimine10-13 ug/mL Clofaziminerespiration

0.235

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.512

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.650

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.166

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.123

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.427

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.376

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.187

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.292

KCN5-20 ug/mL Potassium cyaniderespiration

0.683

NaN30.2-2 mM Sodium aziderespiration

-1.131

Nigericin50 uM Nigericinrespiration

-0.685

TRC10-150 ug/mL Triclosanrespiration

0.461

TRZ10-25 ug/mL Thioridazinerespiration

-0.517

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.743

menadione6-10 ug/mL Menadionerespiration

-0.731

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.537

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.083

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.332

NRP_1Non-replicating persistence stage 1dosRassociated

-0.218

Amp0.2mg/mL AmpicillincellWall

0.314

Cephalexin20-100 ug/mL CephalexincellWall

-0.354

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.139

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.430

EMB10-20 ug/mL EthambutolcellWall

-0.470

Eta12-40 ug/mL EthionamidecellWall

-0.394

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.249

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.181

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.466

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.165

BZA0.12 mg/mL BenzamidearomaticAmides

0.294

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.101

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.096

H2O24 mM hydrogen peroxideDNAdamaging

-0.171

Levo10 ug/mL LevofloxacinDNAdamaging

-0.124

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.425

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.113

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.186

UVUV-irradiationDNAdamaging

0.589

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.174

Antimycin12.5-50 ug/mL Antimycin A?

-0.841

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.612

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.713

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.426

PA8240.2-2 ug/mL PA-824?

-0.897

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.575

Verapamil50 uM Verapamil?

-0.983

mercaptoethanol2 mM 2-Mercaptoethanol?

0.044

methoxatin10-20 ug/mL Methoxatin?